ELARA Trial Evaluates Monthly Aflibercept 8 mg in Pretreated Retinal Diseases
The phase 3b ELARA trial investigates the safety and efficacy of monthly aflibercept 8 mg followed by treat-and-extend dosing in ...
The phase 3b ELARA trial investigates the safety and efficacy of monthly aflibercept 8 mg followed by treat-and-extend dosing in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.